Prelude Capital Management’s Select Medical SEM Stock Holding History

Prelude Capital Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-37,120	Closed	-$472K	–	1872
2022 Q2	$472K	Hold	37,120	–	–	0.01%	843
2022 Q1	$480K	Buy	+37,120	New	+$490K	0.01%	886
2021 Q2	–	Sell	-27,840	Closed	-$512K	–	1921
2021 Q1	$512K	Hold	27,840	–	–	0.01%	882
2020 Q4	$415K	Hold	27,840	–	–	0.01%	788
2020 Q3	$312K	Buy	+27,840	New	+$274K	0.02%	544

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Prelude Capital Management's SEM Position: Q1 2026 in Review

Prelude Capital Management opened a new position in Select Medical (SEM) in Q1 2026: 231,705 shares worth $3.77M. The stake represents 0.29% of the portfolio and ranks #85 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in SEM as recently as Q3 2022.

Prelude Capital Management first reported a position in SEM in Q2 2013 and has held it in 14 quarters since. 277 funds tracked by Wall St. Rank hold SEM as of Q1 2026.

Prelude Capital Management held 231,705 shares of Select Medical worth $3.77M as of Q1 2026.
Select Medical was a new Prelude Capital Management position in Q1 2026.
Select Medical made up 0.29% of Prelude Capital Management's portfolio in Q1 2026, its #85 holding.
Prelude Capital Management first reported a position in Select Medical in Q2 2013 and has held it in 14 quarters since.
277 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.